284 related articles for article (PubMed ID: 31675916)
1. Tracheobronchitis in ulcerative colitis: a case report of therapeutic response with infliximab and review of the literature.
Horgan L; Mulrennan S; D'Orsogna L; McLean-Tooke A
BMC Gastroenterol; 2019 Nov; 19(1):171. PubMed ID: 31675916
[TBL] [Abstract][Full Text] [Related]
2. A rare extraintestinal manifestation of ulcerative colitis: tracheobronchitis associated with ulcerative colitis.
Bayraktaroglu S; Basoglu O; Ceylan N; Aydın A; Tuncel S; Savas R
J Crohns Colitis; 2010 Dec; 4(6):679-82. PubMed ID: 21122581
[TBL] [Abstract][Full Text] [Related]
3. Tracheobronchitis as an extraintestinal manifestation of ulcerative colitis.
Javia S; Agrawal A; Patell R; Jasdanwala S
BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25326560
[TBL] [Abstract][Full Text] [Related]
4. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
5. Ulcerative tracheobronchitis years after colectomy for ulcerative colitis.
Vasishta S; Wood JB; McGinty F
Chest; 1994 Oct; 106(4):1279-81. PubMed ID: 7924516
[TBL] [Abstract][Full Text] [Related]
6. Anti-TNF-A Therapy about Infliximab and Adalimamab for the Effectiveness in Ulcerative Colitis Compared with Conventional Therapy: A Meta-Analysis.
Zhou Z; Dai C; Liu WX
Hepatogastroenterology; 2015 Jun; 62(140):829-37. PubMed ID: 26902011
[TBL] [Abstract][Full Text] [Related]
7. Constrictive bronchiolitis and ulcerative colitis.
Ward H; Fisher KL; Waghray R; Wright JL; Card SE; Cockcroft DW
Can Respir J; 1999; 6(2):197-200. PubMed ID: 10322103
[TBL] [Abstract][Full Text] [Related]
8. [A case of a simple ulcer associated with ulcerative colitis that demonstrated a good clinical response to infliximab].
Kishi M; Sou S; Ishihara H; Terabe H; Yasaka M; Kuhara K; Takeda T; Shimokoube M; Morimitsu Y; Miyazono K
Nihon Shokakibyo Gakkai Zasshi; 2015; 112(9):1682-8. PubMed ID: 26346358
[TBL] [Abstract][Full Text] [Related]
9. Golimumab for moderately to severely active ulcerative colitis.
Kedia S; Ahuja V; Makharia GK
Expert Rev Clin Pharmacol; 2016 Oct; 9(10):1273-82. PubMed ID: 27498886
[TBL] [Abstract][Full Text] [Related]
10. A case of tracheobronchitis in ulcerative colitis: a review of literature.
Kar S; Thomas SG
Clin Respir J; 2009 Jan; 3(1):51-4. PubMed ID: 20298372
[TBL] [Abstract][Full Text] [Related]
11. Tracheobronchitis as an initial presentation of ulcerative colitis.
Shad JA; Sharieff GQ
J Clin Gastroenterol; 2001 Aug; 33(2):161-3. PubMed ID: 11468448
[TBL] [Abstract][Full Text] [Related]
12. Outpatient Ulcerative Colitis Primary Anti-TNF Responders Receiving Adalimumab or Infliximab Maintenance Therapy Have Similar Rates of Secondary Loss of Response.
Ma C; Huang V; Fedorak DK; Kroeker KI; Dieleman LA; Halloran BP; Fedorak RN
J Clin Gastroenterol; 2015 Sep; 49(8):675-82. PubMed ID: 25389599
[TBL] [Abstract][Full Text] [Related]
13. Induction and maintenance infliximab therapy in children with moderate to severe ulcerative colitis: Retrospective, multicenter study.
Iwańczak BM; Kierkuś J; Ryżko J; Szczepanik M; Więcek S; Czaja-Bulsa G; Kacperska M; Korczowski B; Maślana J; Iwańczak F
Adv Clin Exp Med; 2017; 26(1):57-61. PubMed ID: 28397433
[TBL] [Abstract][Full Text] [Related]
14. Contemporary Management of Ulcerative Colitis.
Vanga R; Long MD
Curr Gastroenterol Rep; 2018 Mar; 20(3):12. PubMed ID: 29589185
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: a Korean multicenter retrospective study.
Lee KM; Jeen YT; Cho JY; Lee CK; Koo JS; Park DI; Im JP; Park SJ; Kim YS; Kim TO; Lee SH; Jang BI; Kim JW; Park YS; Kim ES; Choi CH; Kim HJ;
J Gastroenterol Hepatol; 2013 Dec; 28(12):1829-33. PubMed ID: 23829336
[TBL] [Abstract][Full Text] [Related]
16. Late relapse of ulcerative colitis presenting as tracheobronchitis: a case report.
Okamoto S; Koike K; Sekiya M; Nishino K; Mimori T; Takahashi K
J Med Case Rep; 2022 Nov; 16(1):414. PubMed ID: 36320034
[TBL] [Abstract][Full Text] [Related]
17. Tracheobronchitis with dyspnea in a patient with ulcerative colitis.
Hiyoshi M; Kawai K; Shibuya M; Ozawa T; Kishikawa J; Nirei T; Tanaka T; Tanaka J; Kiyomatsu T; Tada T; Kanazawa T; Kazama S; Shoda H; Sumitomo S; Kubo K; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Yamamoto K; Watanabe T
Intern Med; 2015; 54(7):749-53. PubMed ID: 25832936
[TBL] [Abstract][Full Text] [Related]
18. Histological healing after infliximab induction therapy in children with ulcerative colitis.
Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
[TBL] [Abstract][Full Text] [Related]
19. [Acute severe ulcerative colitis treated with accelerated infliximab induction. Case report].
Fluxá D; Flores L; Kronberg U; Moreno M; Figueroa C; Ibáñez P; Lubascher J; Simian D; Quera R
Rev Med Chil; 2017 Aug; 145(8):1083-1088. PubMed ID: 29189869
[TBL] [Abstract][Full Text] [Related]
20. Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis.
Olsen T; Rismo R; Gundersen MD; Paulssen EJ; Johnsen K; Kvamme JM; Goll R; Florholmen J
Cytokine; 2016 Mar; 79():90-5. PubMed ID: 26775117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
